Candidate Profile: Suzanne E. Cuda, MD, ABOM

• Pediatric Committee - Member, Chairperson
• Pediatric Algorithm Committee - Chairperson
• OMA Speaker Bureau - 2021- present
• CME Committee - 2017-2020
• OTF - Secretary Treasurer, 2017-2019

• AAP, general member (1989 - present) and member of the Section on Obesity (2015- present)
• ABOM MOC committee, general member, 2018 - present
• TOS general member (2013- present)
• OAC, general member (2013-present)

First author Pediatric Obesity Algorithm (2016-present)

Executive Editor Obesity Pillars (2021-present)

Associate Professor of Pediatrics, Baylor College of Medicine (2013-2020)

Assistant Professor of Pediatrics, Uniformed Services University of the Health Sciences (1996-2013)

Publications (last 3 years):

i. Binns HJ, Joseph M, Ariza AK, Cuda SE, Skinner AC, Xu H, Tucker JM, Hampl SE, Santos M, Mayo S, King EC, Kirk S; POWER Work Group. Elevated blood pressure in youth in pediatric weight management programs in the Pediatric Obesity Weight Evaluation Registry (POWER). J Clin Hypertens (Greenwich). 2022 Feb;24(2): 122-130. Doi: 10.1111/jch.14423.Epub2022 Jan 31.PMID: 35099099.

ii. Khan MS, Cuda S, Karere GM, Cox LA, Bishop AC. Breath biomarkers of insulin resistance in pre-diabetic Hispanic adolescents with obesity. Sci Rep. 2022 Jan 10:12(1):339. Doi: 10.1038/s41598-021-04072-3.

iii. Skinner AC. Haolin X, Christison A, Neshteruk C, Cuda S, Santos M, Yee JK, Thomas L, King E, Kirk S. Patient retention in Pediatric Weight Management Programs in the United States: Analyses of data from the Pediatric Obesity Weigh Evaluation Registry. 2021; https://doi.org/10/1089/chi.2021.0092.

iv. Borzutzky C, King E, Fox CK, Stratbucker W, Tucker J, Yee JK, Kumar S, Cuda S, Sweeney B, Kirk Se. Trends in Prescribing Anti-Obesity Pharmacotherapy for Pediatric Weight Management: Data from the POWER Work Group. Pediatric Obese 2020; e12701. https://doi.org/10.1111/ijpo.12701.

v. Cuda SE, Censani M. Pediatric Obesity Algorithm: A Practical Approach to Obesity Diagnosis and Management. Front Pediat 2019; 23(6):431. DOI: 10.3389/fped.2018.000431. eCollection2018. Review

vi. Kumar S, King E, Christison A, Kelly A, Ariza A, Borzutzky C, Cuda S, Kirk S. Health Outcomes of Youth in Clinical Pediatric Weight Management Programs in POWER. J Pediatric 2019; 208: 57-65. DOI: 10.1016/jpeds.2018.12.049.Epub2019 Mar 8.

1. Make Obesity Pillars a success: Pillars is the banner for OMA, signifying scientific and academic expertise in clinical management of obesity. This journal is the bridge needed to grow OMA to the next level.
2. Increase the membership in the OMA and sustain the new membership: Membership must continue to grow, both physician and non physician membership. OMA must be seen as the leader in CME for obesity and the leader in clinical management.
3. Increase the CME platform: The CME platform is directly tied to Pillars. Both the CME platform and Pillars should be as seamless as possible and each should refer to the other.

I am the Executive Editor for Pillars and have contributed across the board on the various CME platforms to include teaching in the Review Course, lecturing in the symposia, doing webinars, serving on the CME committee, serving on the Peds committee, serving on the OTF, now serving on the BOT. I am also the first author on the Pediatric Obesity Algorithm and the Editor for the Pediatric self assessment program. I believe that these experiences have prepared me to be instrumental in helping OMA get to the next stage.

I would like to continue to serve on the BOT because I have a vision to enable OMA to expand its CME platform through the development of Pillars together with integration with the Academy. It is such a great opportunity to get this accomplished, but we need to get it well on its way in the next 1-2 years. If I am on the BOT I believe I will be in a position to make sure this occurs as well as help OMA with its other challenges. I have served the OMA is many different roles and I think I am well prepared to do this.

OMA needs to expand its membership and increase its profile. This will increase its stature and help OMA meet its goals. The means to do this is through Pillars and the Academy, specifically the integration of these two platforms. The distinguishing feature between the OMA and other organizations oriented towards the disease of obesity is its CME platform. We need to do everything we can to grow the platform.

Disclosure of Actual or Potential Conflicts of Interest occurring within 1 year of the date of this form and within the foreseeable future:

• Rhythm Pharmaceuticals - Gold Panel Speaker
• Novo Nordisk -Adolescent Advisory Board

Disclosure of ANY interests that could possibly result in a Conflict of Interest in the future with OMA, such as an ownership interest in any business, stock/bond holdings, a grant, an employment relationship, or consultative or advisory arrangement, etc.:

• None

Disclosure of involvement / relationships with other similar or competitive associations / societies which represent interests of obesity medicine clinicians (please specify your level of involvement, i.e. board member, committee leader, committee member, general member, etc.):

• None